By Jane Gregorie, M.S., L.Ac., FABORM Owner & Clinic Director
Introduction
If you have been told at some point that you have PCOS — polycystic ovary syndrome — you may have seen the news this year: as of May 2026, the condition has a new name. Following a 14-year global consensus process led by leading endocrinologists, patient organizations, and 22,000 people worldwide, PCOS is now formally called Polyendocrine Metabolic Ovarian Syndrome, or PMOS.
This is not a rebrand for its own sake. The old name was medically inaccurate, obscured what the syndrome actually is, and — as many patients can attest — contributed to delayed diagnosis, fragmented care, and real stigma.
At Acupuncture Denver, we treat this condition (under both names) every day, and we have watched the international-consensus process unfold with genuine appreciation. This post walks through:
- Why the name changed — and who led the process
- What “Polyendocrine Metabolic Ovarian Syndrome” captures that “polycystic ovary syndrome” missed
- How acupuncture and Chinese herbal medicine address the underlying biology — regardless of what we call it
- What a personalized plan looks like at our clinic
If you already have PCOS/PMOS or suspect you do, this post is a companion to our existing evidence deep-dive on acupuncture for PCOS and fertility — this one focuses specifically on the nomenclature update and what it means for you.
The News: PCOS Is Now PMOS
On May 12, 2026, The Lancet published the multistep global-consensus paper formally renaming the syndrome to Polyendocrine Metabolic Ovarian Syndrome (PMOS) (Teede et al., 2026, The Lancet). The change was simultaneously endorsed by:
- The Endocrine Society
- The International Androgen Excess and PCOS Society (AE-PCOS Society)
- ESHRE (European Society of Human Reproduction and Embryology)
- ASRM (American Society for Reproductive Medicine)
- Verity (PCOS UK)
- More than 50 additional patient and professional organizations worldwide
The process was led by Professor Helena Teede (Monash University), Professor Terhi Piltonen (AE-PCOS Society President), Professor Anuja Dokras (AE-PCOS Society Executive Director), and Rachel Morman (Chair of Verity/PCOS UK). It integrated iterative global surveys from 14,360 people with PCOS/PMOS and health professionals across every world region.
The new name was chosen in a landslide: 87 of 90 voters supported PMOS immediately, with one more coming around by the time the manuscript was submitted. Patient support: 86% of surveyed patients favored the change. Health-care professionals: 71%.
Why the Name Was Changed
The 2026 Lancet consensus statement identified four specific problems with “polycystic ovary syndrome”:
- The name is medically inaccurate. The “cysts” seen on ultrasound in this condition are not cysts at all — they are immature follicles arrested in development. Naming a syndrome after an image finding that doesn’t reflect the actual biology is confusing at best and misleading at worst.
- It obscures the metabolic and endocrine core. The syndrome is fundamentally a combined endocrine and metabolic condition — with insulin resistance, hyperandrogenism, low-grade inflammation, and disrupted HPO-axis signaling — not just an ovarian problem. The old name focused attention on a downstream ovarian finding rather than the upstream drivers.
- It contributes to delayed diagnosis. Patients who did not have visible “polycystic” ovaries on ultrasound (a substantial subgroup under the Rotterdam criteria) often struggled to get diagnosed at all — even when they clearly met the syndrome’s endocrine and metabolic criteria. The name pushed clinicians to look for cysts instead of measuring hormones and metabolic markers.
- It carries stigma. “Polycystic ovary syndrome” implies a defect specific to a reproductive organ, feeding shame and misconception. The new name reframes the condition as a whole-body endocrine and metabolic syndrome that happens to affect the ovaries — which is closer to the truth.
The consensus paper’s framing: the old term is “inaccurate, implying pathological ovarian cysts, obscuring diverse endocrine and metabolic features, and contributing to delayed diagnosis, fragmented care, and stigma” (Teede et al., 2026, The Lancet).
What “Polyendocrine Metabolic Ovarian Syndrome” Actually Captures
The new name is longer, but every word is doing work:
- Polyendocrine — this is a multi-hormone syndrome. Elevated androgens (testosterone, DHEA-S). Elevated LH:FSH ratio. Insulin resistance and compensatory hyperinsulinemia. Frequently subclinical thyroid dysfunction. Sometimes elevated prolactin. Sometimes altered cortisol rhythms.
- Metabolic — the core driver in most patients is insulin resistance, which downstream elevates androgens, disrupts ovulation, and increases risk of type 2 diabetes, dyslipidemia, and cardiovascular disease. This is a metabolic disease that expresses reproductively.
- Ovarian — the ovaries are still where the syndrome shows up most visibly (anovulation, cycle irregularity, hyperandrogenism-mediated fertility challenges, and the follicular-arrest pattern on ultrasound).
- Syndrome — a cluster of features, not a single defect. Different patients have different phenotypes under the same diagnosis.
Under PMOS, the diagnostic framework itself is largely unchanged — the current Rotterdam criteria (any two of: hyperandrogenism, ovulatory dysfunction, polycystic ovarian morphology on ultrasound) still apply. What has changed is the emphasis: metabolic evaluation is now a core part of the workup, not an afterthought, and the four Rotterdam phenotypes are more clearly recognized rather than lumped under a single “cysts” heading.
How Common Is PMOS?
- 1 in 8 women of reproductive age are affected — more than 170 million people worldwide (Endocrine Society, 2026 press release)
- It is the most common endocrine disorder in reproductive-age women
- It is a leading cause of anovulatory infertility
- It is a major contributor to type 2 diabetes risk, cardiovascular disease risk, endometrial cancer risk, and depression/anxiety
Despite that prevalence, average time to diagnosis is over 2 years, and many patients see 3+ clinicians before they get answers. That gap is exactly what the name change is designed to close.
How Acupuncture and Chinese Medicine Address PMOS
The change in name has not changed the underlying biology of the syndrome. What acupuncture and Chinese herbal medicine were doing well for PCOS, they continue to do well for PMOS — and the metabolic-forward reframing actually strengthens the case for integrative care, because so much of what acupuncture affects is exactly the metabolic and endocrine machinery that the new name centers.
Here are the specific pathways where the evidence base is meaningful.
1. Insulin Sensitivity and Metabolic Function
Insulin resistance is now recognized as the central metabolic driver in most PMOS patients. High insulin drives ovarian testosterone production, disrupts ovulation, and increases cardiovascular risk over time.
Acupuncture has been shown to improve insulin sensitivity, likely through modulation of the sympathetic nervous system and metabolic signaling pathways. This is one of the most-studied areas of acupuncture in PMOS — foundational work by Stener-Victorin and colleagues demonstrated that repeated low-frequency electroacupuncture improved ovulation frequency and reduced high-testosterone patterns in women with PMOS (Stener-Victorin et al., 1996 uterine-artery Doppler foundational work, with follow-up work through the 2010s).
2. Restoring Ovulation
Ovulatory dysfunction is a defining feature of PMOS. Acupuncture appears to support ovulation through modulation of the hypothalamic-pituitary-ovarian (HPO) axis — supporting GnRH pulsatility and normalizing LH and FSH signaling.
A meta-analysis of acupuncture combined with clomiphene for PMOS patients found that acupuncture + moxibustion + clomiphene improved ovulation and pregnancy rates compared to clomiphene alone (Meta-analysis of acupuncture + moxibustion + clomiphene in PMOS, PMC10698371).
A separate meta-analysis of acupuncture combined with letrozole — increasingly first-line for PMOS ovulation induction — showed significant improvements in clinical pregnancy rates, ovulation rates, serum estradiol, and endometrial thickness (Meta-analysis of acupuncture + letrozole in PMOS, 2025, European Journal of Obstetrics & Gynecology and Reproductive Biology).
3. Reducing Hyperandrogenism
Elevated androgens drive the acne, hirsutism (unwanted hair growth), scalp hair loss, and mood effects that many PMOS patients live with. Acupuncture appears to modulate androgen levels through effects on ovarian steroidogenesis and adrenal function. Chinese herbal medicine, particularly patterns and formulas addressing Phlegm-Damp accumulationand Liver Qi Stagnation with heat, has traditional and increasingly documented effects on the underlying signaling.
4. Anti-Inflammatory Effects
Low-grade systemic inflammation is a recognized feature of PMOS and part of what links it to cardiovascular risk. Acupuncture has documented anti-inflammatory effects through vagal-nerve activation of the cholinergic anti-inflammatory pathway — supporting the endocrine and metabolic pillars simultaneously.
5. Nervous-System Regulation and Stress Physiology
Chronic sympathetic activation exacerbates every dimension of PMOS — insulin resistance, HPO-axis disruption, sleep problems, and mood. Acupuncture reliably shifts the body into parasympathetic tone. See our companion post on acupuncture for stress and fertility.
6. Supporting Weight and Body Composition (When Relevant)
Not all PMOS patients have weight-related concerns — lean PMOS is a distinct and often under-recognized phenotype — but for those where insulin resistance and weight are part of the picture, acupuncture may support metabolic function in ways that make lifestyle changes more effective.
Traditional Chinese Medicine Perspective on PMOS
In Traditional Chinese Medicine, PMOS is understood as a pattern of imbalance rather than a single diagnosis. The same PMOS diagnosis may express as very different patterns from patient to patient — and treatment is tailored to the underlying pattern rather than the label.
Phlegm-Damp Accumulation
The pattern most commonly associated with:
- weight gain, particularly around the midsection
- insulin resistance
- heavy or absent periods with a “stuck” quality
- fatigue after meals, sugar cravings
- often the “classic” PMOS presentation
Treatment transforms Damp and Phlegm with formulas like Cang Fu Dao Tan Tang — supporting insulin sensitivity and metabolic function.
Liver Qi Stagnation
Associated with:
- premenstrual irritability, breast tenderness, bloating
- stress-driven cycle irregularity
- hormonal disruption tied to stress load
Treatment smooths Liver Qi with formulas like Xiao Yao San or Jia Wei Xiao Yao San.
Kidney Yang Deficiency
Associated with:
- low basal body temperatures, cold extremities
- absent ovulation, anovulation
- low libido
- often present with lean PMOS
Treatment warms Kidney Yang with formulas like You Gui Wan.
Blood Stasis
Associated with:
- painful periods, dark or clotted flow
- long-standing anovulation with underlying stagnation
- overlap with endometriosis in some patients
Treatment moves stagnant blood with formulas like Gui Zhi Fu Ling Wan.
Heat in the Blood
Associated with:
- acne, oily skin
- hirsutism
- hot temperament, irritability
- shorter cycles
Treatment clears Heat while addressing the constitutional root.
Most PMOS patients present with combinations of these patterns — most commonly Phlegm-Damp Accumulation layered onto Kidney or Liver imbalances. Identifying the pattern is what allows for individualized formulas and point selection.
What a Personalized PMOS Plan Looks Like at Acupuncture Denver
For our PMOS patients — whether the immediate goal is fertility, symptom management, or long-term metabolic health — a typical plan includes:
- Comprehensive intake and TCM pattern diagnosis — cycle history, full workup review, insulin/glucose labs, thyroid panel, androgens, AMH, and any imaging
- Weekly acupuncture sessions with electroacupuncture — insulin-sensitizing points, ovulation-supporting points, and HPO-axis-modulating protocols
- Custom Chinese herbal formulas — pattern-specific and cycle-phase-specific
- Targeted supplement protocol — most commonly myo-inositol + D-chiro-inositol in a 40:1 ratio, along with the foundational fertility supplement stack (see our post on evidence-based fertility supplements); NAC and berberine for insulin resistance when appropriate
- Coordination with your medical team — endocrinologist, reproductive endocrinologist if TTC, OB-GYN, primary care — especially if you are on or considering metformin, letrozole, clomiphene, or GLP-1 medications
- Dietary therapy — low-glycemic, anti-inflammatory eating patterns; adequate protein; warm cooked meals as the default (see our Four Pillars framework)
- Stress and sleep regulation — critical for the sympathetic-tone side of the metabolic picture
- Red light therapy and infrared sauna for anti-inflammatory and metabolic support
- If TTC — cycle-phase-specific protocols per our acupuncture for PCOS fertility post and — if IUI or IVF is in the plan — coordination with your reproductive endocrinologist. See also our posts on acupuncture for IUI and IVF/embryo transfer
When to Start Acupuncture for PMOS
PMOS is a chronic condition — treatment is not a 3-visit intervention. For meaningful change, plan for:
✔ Weekly acupuncture for a minimum of 3 months for cycle regulation and initial symptom shifts ✔ 6+ months for meaningful metabolic and androgen changes ✔ 12+ months as an ongoing wellness rhythm — PMOS is a lifetime condition, and long-term integrative care is one of the highest-value investments you can make ✔ If TTC: minimum 3 months of preparation before conception attempts or IVF, longer if AMH is elevated or ovulation is not yet regular
Clinical Insight from Our Practice
At Acupuncture Denver, our PMOS patients most commonly report:
- more regular and predictable cycles within 2–4 months
- reduced acne, oiliness, and hirsutism over 6–12 months
- lower fasting insulin and improved glucose regulation on repeat labs
- better sleep, mood, and stress tolerance
- when TTC: return of ovulation, pregnancy — sometimes after years of anovulation
- a sense of understanding their condition rather than fighting against a confusing label
Many also feel real relief at the new name itself. “Cystic” was never accurate, and hearing the syndrome called what it actually is — a polyendocrine, metabolic, whole-body condition — has been meaningful for many of our patients.
Jane, Merry, and Mally are all ABORM board-certified Reproductive Medicine Specialists with over two decades of experience treating this syndrome. We work alongside Denver-area endocrinologists, reproductive endocrinologists, and OB-GYNs.
Patient Takeaways
If you have PCOS/PMOS:
✔ The condition has a new name as of May 2026: Polyendocrine Metabolic Ovarian Syndrome (PMOS) — a global consensus reached after 14 years, 22,000 voices, and 56 organizations ✔ The new name reflects that this is a whole-body endocrine and metabolic syndrome, not an “ovarian cyst disease” ✔ The Rotterdam diagnostic criteria are largely unchanged; the emphasis on metabolic workup is strengthened ✔ Acupuncture and Chinese medicine address the underlying biology — insulin sensitivity, HPO axis, androgens, inflammation, stress physiology — with a meaningful evidence base for combined use with letrozole, clomiphene, and lifestyle interventions ✔ Plan for at least 3 months for initial cycle changes and 6–12+ months for deeper metabolic and androgen shifts ✔ The Four Pillars framework — acupuncture, Chinese herbs, red light therapy, and dietary therapy — is a proven fit for PMOS
Considering Acupuncture and Chinese Medicine for PMOS?
If you have PCOS/PMOS — whether newly diagnosed, long-standing, TTC, or focused on symptom management — we would be honored to design a personalized plan around your:
- specific PMOS phenotype (classic, lean, ovulatory, non-hyperandrogenic)
- immediate goals (fertility, cycle regulation, acne/hair, weight/metabolic, mood, prevention)
- complete workup and any medications
- TCM pattern and constitutional picture
👉 Schedule your consultation to begin a personalized PMOS plan.
For our full evidence-based PCOS/PMOS fertility deep-dive, see our companion post on acupuncture for PCOS and fertility. For the broader integrative framework, see The Four Pillars of Integrative Fertility Care.
Frequently Asked Questions
Why was PCOS renamed to PMOS?
The name change — published in The Lancet in May 2026 after a 14-year global consensus process — reflects that “polycystic ovary syndrome” was medically inaccurate. The “cysts” seen on ultrasound are actually immature follicles arrested in development. The syndrome is fundamentally a polyendocrine and metabolic condition — with insulin resistance, hyperandrogenism, and disrupted HPO-axis signaling — not an ovarian cyst disease. The old name contributed to delayed diagnosis, fragmented care, and stigma.
What does PMOS stand for?
Polyendocrine Metabolic Ovarian Syndrome. Every word does work: polyendocrine (multiple hormone systems affected), metabolic (insulin resistance is central), ovarian (where the syndrome most visibly shows up), syndrome (a cluster of features, not a single defect).
Do the diagnostic criteria change under PMOS?
The current Rotterdam criteria (any two of: hyperandrogenism, ovulatory dysfunction, polycystic ovarian morphology on ultrasound) remain the diagnostic framework. What has changed is the emphasis: metabolic evaluation is now a core part of the workup, and the four Rotterdam phenotypes are more explicitly recognized rather than lumped under one heading.
How common is PMOS?
PMOS affects approximately 1 in 8 women of reproductive age — more than 170 million people worldwide. It is the most common endocrine disorder in reproductive-age women.
Can acupuncture and Chinese medicine help PMOS?
Yes. Acupuncture has evidence-supported effects on the core PMOS drivers: insulin sensitivity, HPO-axis regulation, ovulation, androgen levels, inflammation, and stress physiology. Meta-analytic evidence supports acupuncture combined with clomiphene or letrozole for improved ovulation and pregnancy rates in PMOS patients. Chinese herbal medicine adds a sustained action between sessions, individualized to the underlying TCM pattern.
Does the name change affect my treatment plan?
Not directly. The underlying biology and the standard-of-care approach remain the same. What may change is the emphasis of your workup — expect your clinician to include a fuller metabolic evaluation (fasting insulin, glucose, HbA1c, lipid panel) and, in some cases, evaluation for thyroid dysfunction, prolactin, and cortisol rhythms. Acupuncture and Chinese medicine were addressing these systems all along; the new framing simply makes the case for that integrative approach clearer.
What supplements should I consider for PMOS?
The strongest evidence supports myo-inositol + D-chiro-inositol in a 40:1 ratio for insulin sensitivity, ovulation, and pregnancy rates in ART cycles. Also relevant: vitamin D3 (if deficient), omega-3s, magnesium, NAC (moderate evidence for PMOS), and potentially berberine for insulin resistance. See our full evidence-based fertility supplements post for the evidence tiers and dosing.
Is there “lean PMOS”?
Yes. Lean PMOS is a real and under-recognized phenotype — women with the syndrome who are at normal or low BMI. Insulin resistance can still be present (measured on fasting insulin or HbA1c rather than assumed from weight), and the ovarian and androgen features can be equally prominent. If you have irregular cycles, hyperandrogenism, or ovulatory dysfunction and were told “you can’t have PCOS because you’re not overweight,” ask for a proper workup — the metabolic evaluation is the key.
How long before I see changes from acupuncture and Chinese medicine?
Most patients notice cycle changes within 2–4 months of consistent weekly acupuncture plus custom herbs. Deeper metabolic and androgen shifts typically take 6–12 months. For TTC-focused care, plan for at least 3 months of preparation before conception attempts or IVF, longer if anovulation has been long-standing.
Is acupuncture safe with metformin, letrozole, clomiphene, or GLP-1 medications?
Yes. Acupuncture has no known interactions with any of these medications. Chinese herbal formulas are cross-checked against your full medication list at every visit — our practitioners are NCCAOM board-certified and trained in herb-drug interaction screening. We coordinate directly with your medical team when any adjustment is warranted.
References
- Teede, H. J., Piltonen, T., Dokras, A., Morman, R., et al. (2026). Polyendocrine metabolic ovarian syndrome, the new name for polycystic ovary syndrome: a multistep global consensus process. The Lancet.
- Endocrine Society. (2026, May 12). Polyendocrine Metabolic Ovarian Syndrome: New name to improve diagnosis and care of condition affecting 170 million women worldwide. Press release.
- American Society for Reproductive Medicine. (2026, May 27). PCOS is Now PMOS: Understanding the Name Change.
- ESHRE. (2026). PCOS is renamed following unprecedented international consensus. Focus on Reproduction.
- Teede, H. J., et al. (2023). International Evidence-Based Guideline for the Assessment and Management of Polycystic Ovary Syndrome. The Journal of Clinical Endocrinology & Metabolism (co-published in Fertility and Sterility, European Journal of Endocrinology, Human Reproduction).
- Fitz, V., Graca, S., Mahalingaiah, S., et al. (2024). Inositol for Polycystic Ovary Syndrome: A Systematic Review and Meta-analysis to Inform the 2023 Update of the International Evidence-based PCOS Guidelines. The Journal of Clinical Endocrinology & Metabolism, 109(6), 1630–1655.
- (2023). Meta-analysis of ovulation induction effect and pregnancy outcome of acupuncture & moxibustion combined with clomiphene in patients with polycystic ovary syndrome. PMC10698371.
- (2025). Meta-Analysis of the Effects of Acupuncture Combined With Letrozole on Ovulation Induction and Pregnancy Outcomes in Patients With Polycystic Ovary Syndrome. European Journal of Obstetrics & Gynecology and Reproductive Biology.
- (2025). The effect of myo-inositol on assisted reproductive technology outcomes in women with polycystic ovarian syndrome: A systematic review and meta-analysis of randomized clinical trial studies. PMC12413536.
- Stener-Victorin, E., et al. (1996). Reduction of blood flow impedance in the uterine arteries of infertile women with electro-acupuncture. Human Reproduction, 11(6), 1314–1317. (Foundational uterine-artery Doppler work; Stener-Victorin’s later PCOS-specific electroacupuncture research established the ovulation-and-androgen mechanism base.)
Medical disclaimer: This article is for educational purposes only and is not a substitute for personalized medical care. PMOS (formerly PCOS) is a chronic condition that benefits from evaluation and coordinated care by an endocrinologist, reproductive endocrinologist, or OB-GYN alongside integrative care. Acupuncture and Chinese herbal medicine should be provided by a licensed, board-certified practitioner with advanced fertility training, in coordination with your medical team.
